Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 8, 2018
Brainstorm to Announce First Quarter Financial Results and Provide Corporate Update on Monday, May 14
NEW YORK and PETACH TIKVAH, Israel, May 8, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for ...
May 8, 2018
iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018
NASHUA, N.H., May 08, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the ...
May 8, 2018
Altimmune to Announce First Quarter 2018 Financial Results on May 16
GAITHERSBURG, Md., May 08, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the ...
May 8, 2018
CymaBay Therapeutics Announces the Initiation of a Phase 2b Study of Seladelpar in Patients with Non-Alcoholic Steatohepatitis
NEWARK, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
May 8, 2018
UroGen Pharma to Report First Quarter 2018 Financial Results on Tuesday, May 15, 2018
RA’ANANA, Israel and NEW YORK, May 08, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN) today announced that it will report first quarter 2018 financial ...
May 8, 2018
Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
AUSTIN, Texas, May 08, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
May 8, 2018
Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
WARREN, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that, following the receipt ...
May 8, 2018
Rockwell Medical Update on Calcitriol New Manufacturing Submission to FDA
WIXOM, Mich., May 08, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), today provided an update on its new manufacturing submission for its Calcitriol vitamin ...
May 7, 2018
OSE Immunotherapeutics Presents New Data on OSE-127 at the American Association of Immunologists (AAI) Annual Meeting May 4-8 2018 in Austin, Texas
NANTES, France, May 07, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE) presented new preclinical data* that further supports the potential of OSE-127 for the treatment of ...
May 7, 2018
Aptose Exercises Early Option for CG-806 License From CrystalGenomics
SAN DIEGO and SEOUL, South Korea, May 07, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO) and CrystalGenomics, Inc. (083790.KQ) today announced that Aptose ...
May 7, 2018
Keryx Biopharmaceuticals to Host Conference Call of First Quarter 2018 Financial Results on Thursday, May 10, 2018
BOSTON, May 07, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today ...
May 7, 2018
Auris Medical Receives Positive Scientific Advice from EMA on Development Plan and Regulatory Pathway for AM-111
Zug, Switzerland, May 7, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
May 7, 2018
VBL Therapeutics to Present Data on its MOSPD2 Oncology Program at MIXiii-BIOMED 2018 on May 15
TEL AVIV, Israel, May 07, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
May 7, 2018
BioDelivery Sciences Appoints Herm Cukier as Chief Executive Officer
RALEIGH, N.C., May 07, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
May 7, 2018
Lipocine Announces Financial and Operational Results for the First Quarter Ended March 31, 2018
SALT LAKE CITY, May 7, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, ...
May 7, 2018
BrainsWay Receives FDA Clearance of Next Generation Stimulator, Enhancing Its Current Deep Transcranial Magnetic Stimulation (Deep TMS) System for Treatment of Major Depressive Disorder
HACKENSACK, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BRIN.TA), the parent company of BrainsWay USA, Inc., and a global leader in the advanced ...
May 7, 2018
Foamix Announces Dosing of Last Patient in Third Phase 3 Acne Study for Minocycline Foam FMX101
REHOVOT, Israel, and BRIDGEWATER, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (FOMX), a clinical stage specialty pharmaceutical company focused on developing and ...
May 7, 2018
Rexahn Reports First Quarter 2018 Financial Results
ROCKVILLE, Md., May 07, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment ...
May 7, 2018
HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis’ Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology
TUCSON, Ariz. and HUNINGUE, France, May 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (“HTG”), a provider of instruments, reagents and services for ...
May 7, 2018
Krystal Biotech Reports First Quarter 2018 Financial Results and Provides Corporate Update
PITTSBURGH, May 07, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech (KRYS), a gene therapy company advancing “off-the-shelf” topical and intra-dermal treatments for dermatological diseases, today reports ...
Page 44 of 117